We are looking for children aged 2 to 17 years to join a Crohn’s disease (CD) trial to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or IBD (including associated symptoms such as abdominal pain or cramping, diarrhea, abdominal pain, malnutrition and/or anemia), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the IBD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local Crohn’s disease study is testing a potential new medication to see if it may reduce fatigue, stomach pain, bloody stool, weight loss, and/or anemia associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the Crohn’s disease study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for children 2–17 years old to join a research to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or moderate to severe IBD (including associated symptoms such as abdominal pain and cramps, diarrhea, cramps, weight loss and/or eye pain), consider one of our clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing moderate to severe CD flare-ups? Local Crohn’s disease (CD) research study is testing a potential new medication to see if it may reduce abdominal cramping, stomach pain, cramps, weight loss, and/or liver disease associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the Crohn’s disease (CD) research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for 2 to 17 years of age to join a UC clinical research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderately to severely active ulcerative colitis (including associated symptoms such as fatigue, unexplained weight loss, abdominal pain, frequent fevers and/or eye pain), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing gastrointestinal disease flare-ups? Local Crohn’s disease (CD) clinical trial is testing a potential new medication to see if it may reduce abdominal pain and cramps, reduced appetite, diarrhea, malnutrition, and/or eye pain associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the Crohn’s disease (CD) clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for teen to join a Crohn’s disease study to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or Crohn’s and UC (including associated symptoms such as diarrhea with pus, abdominal cramps, diarrhea, frequent fevers and/or liver disease), consider one of our GI medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the GI medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing moderate to severe IBD flare-ups? Local Crohn’s disease study is testing a potential new medication to see if it may reduce tiredness, loss of appetite, bloody stool, chronic fatigue, and/or joint pain associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the Crohn’s disease study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for children at least 2 years of age but under 18 to join a clinical research study to help us discover more about treating Crohn’s and UC. If you are looking for a potential new treatment option for Crohn’s and UC or Crohn’s disease (including associated symptoms such as cramps, joint pain, cramps, chronic fatigue and/or eye pain), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing Crohn’s disease flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce abdominal cramps, inflammation of the bowel or intestine, constant need to poop, malnutrition, and/or anemia associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.